fbpx Skip to main content


Nauman Shah



Nauman Shah is Global Head, Janssen Business Development. In this role, Nauman leads the Janssen Business Development organization in the identification, evaluation, execution, integration and management of global licensing, mergers & acquisitions (M&A), divestitures and out-licensing deals for the Janssen Pharmaceutical Companies of Johnson & Johnson.

Previously, Nauman was Chief Strategic Customer Officer, Johnson & Johnson Medical Devices, with responsibility for driving access and partnering strategies. Under his leadership, the Strategic Customer team developed and launched strategic value-based care programs that enhance operational efficiency for healthcare systems and implemented innovative contracting strategies and capabilities that leverage data science and analytics in decision-making. Nauman has championed initiatives to evolve our business models and to address healthcare disparities, in partnership with stakeholders across the healthcare ecosystem. He is also the leader for the Johnson & Johnson Medical Devices business in Canada with oversight for the entire portfolio and leads the North America Commercial Council.

In the past, Nauman served as Vice President, Enterprise Program Management Office (EPMO) where he was Chief-of-Staff for Alex Gorsky. He worked closely with the Executive and Management Committees to drive the Company’s strategic planning process, to advance and execute enterprise growth initiatives and to lead key strategic projects. Before his Enterprise role, Nauman held roles of increasing responsibility in sales, marketing, and portfolio management within the Pharmaceuticals sector for more than 20 years. During his tenure, he helped evaluate several licensing opportunities in collaboration with Business Development and worked closely with partner companies as well as our R&D organization on the development programs and launch plans for major products, including XARELTO® and INVOKANA®.

Prior to joining Johnson & Johnson, Nauman worked at Pfizer/Pharmacia, where he played a significant role in the successful launches of three major products in the areas of urology, arthritis, and pain.

Nauman holds a Bachelor of Arts in Biological Basis of Behavior from the University of Pennsylvania and a Master of Business Administration in Finance from Temple University. He also graduated from the Wharton School of the University of Pennsylvania after completing the General Management Program.